New FDA ZOCOR® Warnings
March 2010 - FDA announces study results that demonstrate an increased risk (up to 50% higher) of rhabdomyolysis for patients who are taking an 80mg dose of Zocor® when compared to those taking a 20mg dose of Zocor®. The FDA originally approved Zocor® in 1991, and concerns have arisen regarding side effects from higher dosages of Zocor® as well as the generic version of Zocor® known as Simvastatin®.
If you are taking a dosage of Zocor® or Simvastatin® which is 80mg or higher, and have developed rhabdomyolysis you may have a strong case against the manufacturers of Zocor® and Simvastatin®. The manufacturer of Zocor®, Merck, should have warned you about the increased risks associated with Zocor®, Simvastatin® and the development of rhabdomyolysis.
Contact an Experienced Ohio Zocor® Attorney
Anyone diagnosed with rhabdomyolysis while taking Zocor® or Simvastatin® may have a claim. Clark, Perdue & List has substantial experience with pharmaceutical injury claims. If you or someone you know has suffered serious side effects from the use of Zocor® or Simvastatin®, call us toll free at (866) 603-1668, or e-mail the experienced pharmaceutical injury attorneys at Clark, Perdue & List today.
